Form 4: Lattice Semiconductor SVP, General Counsel Tracy Ann Feanny Reports Stock Sales
SEC Form 4 Filing
Tracy Ann Feanny, SVP, General Counsel of Lattice Semiconductor, reported selling shares of common stock on February 26, 2024, under a pre-arranged 10b5-1 plan.
Summary
- On February 26, 2024, Tracy Ann Feanny, the SVP, General Counsel of Lattice Semiconductor Corp, sold shares of the company's common stock.
- The sales were executed under a pre-approved 10b5-1 trading plan adopted on August 26, 2022.
- Two transactions occurred: one involving the sale of 5,767 shares at a weighted average price of $75.08, and another involving the sale of 551 shares at a price of $75.75.
- Following these transactions, Feanny directly owns 11,908 shares of Lattice Semiconductor common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing plan. It doesn't inherently indicate positive or negative news about the company.
Industry Context
This filing is a routine disclosure of stock sales by a company insider. It's common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of insider trading. The semiconductor industry is closely watched for insider activity as it can provide insights into company performance.
Comparison to Industry Standards
- Monitoring insider trading activity is a common practice in the semiconductor industry.
- Companies like AMD, Nvidia, and Intel are also subject to similar scrutiny regarding executive stock transactions.
- The use of 10b5-1 plans is a standard method for executives to manage their stock holdings while complying with regulations.
Stakeholder Impact
- The stock sales by an executive could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 08/26/2022 | Adoption date of the 10b5-1 trading plan. |
| 02/26/2024 | Date of the stock sale transactions. |
| 02/27/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.